This study is exploring a treatment for people with certain neurologic disorders, including those affecting the nervous system, neurodegenerative diseases, and stroke. The treatment involves using your own bone marrow derived stem cells (BMSC), which are special cells from your bone marrow. These cells are given to you through an IV (into a vein) and intranasally (into the lower part of your nose). Researchers want to see if this treatment can improve your neurologic function. To join, you must be at least 18 years old, have documented functional damage to your central or peripheral nervous system that isn't likely to improve with standard care, and be at least 6 months past the start of your disease. If you are on current medical therapy, you must be stable on that treatment. The study aims to enroll 500 participants.

Study design

This is an interventional study with a planned enrollment of 500 participants. The phase of the study is not specified.

What's involved

Participants will receive autologous bone marrow derived stem cells intravenously and intranasally. Neurologic function will be measured at 0, 1, 3, 6, and 12 months.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 12 months after treatment to measure changes in neurologic function.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.